establishment vaccine infection recent years pharmaceutical companies indicated waning interest vaccine development emergency vaccine efforts combat sudden epidemics especially expensive risky ventures disruptive not way want business going forward rip ballou director u.s. research development center gsk global vaccines told stat news january novartis closed vaccine division 2014 u.s. money controlling infectious disease tends stop things improve says ron valdiserri senior research associate johns hopkins bloomberg school public health deputy assistant secretary health responsible infectious diseases u.s. department health human services notion oh good handle disease forget says infectious diseases successful reduce new infections reduce incidence spring hiv following pattern